Recent News

• 05.13.2025 - On resilience: stories of strength and hope from the AL amyloidosis community
• 05.01.2025 - Prothenians at AD/PD 2025, where innovation meets inspiration
• 03.28.2025 - “Being a patient changed my life forever,” Part Two — Amyloidosis Research Consortium founder and CEO, Isabelle Lousada, shares how the organization was born, and how it supports patients today
• 03.21.2025 - “Being a patient changed my life forever,” Part One — Shining a light on Isabelle’s story this Amyloidosis Awareness Month
• 03.07.2025 - A transformational year: President and CEO Dr. Gene Kinney discusses what lies ahead for Prothena in 2025

Recent Filings

• 05.08.2025 - 8-K Current report
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.06.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - 3 Initial statement of beneficial ownership of securities
• 03.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.28.2025 - DEF 14A Other definitive proxy statements
• 03.28.2025 - ARS Annual Report to Security Holders